Alliance Wealth trimmed its Gilead stake by 31.7% in Q4 (9,157 shares), while other institutions bought more. Gilead beat Q4 estimates, raised its dividend, and holds a Moderate Buy rating with a $157.35 target.Abstract: This note reviews Q4 moves in Gilead Sciences stock. Alliance Wealth Advisors UT reduced its stake by 31.7% (9,157 shares) even as other investors increased holdings. Gilead reported stronger-than-expected Q4 earnings and raised its quarterly dividend. Analysts maintain a Moderate Buy rating with a $157.35 price target, signaling cautious optimism about the stock's near-term outlook.

NodeGuardian

2026-05-08 17:06:22

Abstract generation in progress

Alliance Wealth Advisors LLC UT significantly reduced its stake in Gilead Sciences by 31.7% in Q4, selling 9,157 shares. Despite this, other institutional investors increased their positions, and Gilead Sciences reported strong Q4 earnings, beating estimates and raising its quarterly dividend. The company maintains a “Moderate Buy” consensus rating from analysts, with a target price of $157.35.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GateSquareMayTradingShare
1.02M Popularity
#
BTCBackAbove80K
59.44M Popularity
#
JapanTokenizesGovernmentBonds
1.9M Popularity
#
DailyPolymarketHotspot
868.14K Popularity
#
WCTCTradingKingPK
754.12K Popularity

Sitemap

Alliance Wealth Advisors LLC UT Cuts Stake in Gilead Sciences, Inc. $GILD

Trending Topics

GateSquareMayTradingShare

BTCBackAbove80K

JapanTokenizesGovernmentBonds

DailyPolymarketHotspot

WCTCTradingKingPK

Pin